quinazolines has been researched along with cucurbitacin b in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alp, E; Elmazoglu, Z; Menevse, S; Yar Saglam, AS | 1 |
1 other study(ies) available for quinazolines and cucurbitacin b
Article | Year |
---|---|
Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; ErbB Receptors; Gefitinib; HCT116 Cells; HT29 Cells; Humans; Janus Kinases; Microscopy, Fluorescence; Quinazolines; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT Transcription Factors; Triterpenes | 2016 |